Drug Profile
DC-Vac/IR injection
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Binex
- Class Antineoplastics; Cell therapies; Immunotherapies
- Mechanism of Action Cell replacements; Immunologic cytotoxicity
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Colorectal-cancer in South Korea (Parenteral, Injection)
- 03 Aug 2016 Peclinical trials in Colorectal cancer in South Korea (Parenteral)